Amphastar Pharmaceuticals, Inc. (29A.F)
Frankfurt - Frankfurt Delayed Price. Currency in EUR
Add to watchlist
At close: 08:05AM CEST
| Previous Close | 36.90 |
| Open | 37.35 |
| Bid | 37.52 x 70000 |
| Ask | 38.05 x 70000 |
| Day's Range | 37.35 - 37.35 |
| 52 Week Range | 35.50 - 59.00 |
| Volume | |
| Avg. Volume | 2 |
| Market Cap | 1.844B |
| Beta (5Y Monthly) | 0.82 |
| PE Ratio (TTM) | 13.78 |
| EPS (TTM) | 2.71 |
| Earnings Date | Aug 06, 2024 - Aug 12, 2024 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 22.75 |
GuruFocus.comInsider Sale: Director Floyd Petersen Sells Shares of Amphastar Pharmaceuticals Inc (AMPH)
On June 10, 2024, Floyd Petersen, Director at Amphastar Pharmaceuticals Inc (NASDAQ:AMPH), executed a sale of 3,000 shares of the company.
Simply Wall St.With EPS Growth And More, Amphastar Pharmaceuticals (NASDAQ:AMPH) Makes An Interesting Case
For beginners, it can seem like a good idea (and an exciting prospect) to buy a company that tells a good story to...
ACCESSWIREAmphastar Announces Additional $50 Million Increase to its Share Buyback Program
RANCHO CUCAMONGA, CA / ACCESSWIRE / June 4, 2024 / Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) today announced that on June 3, 2024, the Company's Board of Directors authorized a $50 million increase to the Company's share buyback program, which ...
© 2024 Yahoo. All rights reserved.